Viewing Study NCT02628405


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-03-04 @ 12:44 PM
Study NCT ID: NCT02628405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-01
First Post: 2015-12-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
Sponsor: Academic and Community Cancer Research United
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-05-20
Start Date Type: ACTUAL
Primary Completion Date: 2021-09-24
Primary Completion Date Type: ACTUAL
Completion Date: 2025-12-20
Completion Date Type: ESTIMATED
First Submit Date: 2015-12-09
First Submit QC Date: None
Study First Post Date: 2015-12-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2024-03-20
Results First Submit QC Date: None
Results First Post Date: 2024-07-01
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-27
Last Update Post Date: 2024-07-01
Last Update Post Date Type: ACTUAL